Evidence map›Paper›PMID 42722776›Full record

ArticleJournal of neuro-oncology2026

Assessing the personal financial impact of vestibular schwannoma management.

Robert J Macielak, William Liu, Nicholas S Andresen, Yin Ren, Edward E Dodson, Daniel M Prevedello, Oliver F Adunka, Kyle C Wu, Desi P Schoo

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Robert J MacielakDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA. robertmacielak@gmail.com.
William LiuThe Ohio State University College of Medicine, Columbus, OH, USA.
Nicholas S AndresenDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA.
Yin RenDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA.
Edward E DodsonDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA.
Daniel M PrevedelloDepartment of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Oliver F AdunkaDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA.
Kyle C WuDepartment of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Desi P SchooDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the personal financial impact of vestibular schwannoma (VS) management through a survey hosted by the Acoustic Neuroma Association (ANA).

methodsA cross-sectional survey was created to ask participants with a VS questions relating to their personal finances and employment with a specific emphasis on financial toxicity, with this toxicity being measured through the COmprehensive Score for financial Toxicity (COST) assessment and the Financial Distress Questionnaire (FDQ).

resultsAt the time of study completion, 41 respondents had fully completed the provided survey, with the majority being > 50-years-old at the time of intervention (24 participants, 59%) and female (33 participants, 80%). Twenty-nine participants (71%) reported undergoing microsurgical resection of their VS, 9 (22%) documented undergoing radiation therapy, and 3 (7%) described undergoing a combination of both modalities. After initiation of management, 11 respondents (27%) experienced a change in employment and 17 (41%) experienced a change in their duties at work, including change in hours, reduced activity, or new unemployment. The median score on the COST questionnaire was 32 (IQR 15-39). On the FDQ, only 4 respondents (10%) were noted to have moderate financial toxicity and 2 (5%) reported severe financial toxicity.

conclusionsAmong surveyed VS patients after treatment, change in employment as well as job duties can be observed; however, the ultimate financial toxicity of these changes appears limited, with few patients experiencing substantial financial hardship. Further study of this point through prospective study could better identify risk factors associated with personal financial difficulty and improve generalizability.

Indexed as

Cost of IllnessEmploymentNeuroma, AcousticAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesFinancial ToxicityMicrosurgeryObservationPersonal FinancesRadiosurgeryVestibular Schwannoma

Identifiers

PMID42722776

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.